Oracle (Clinical) is a major dominant player in the global CRO - Clinical Research Organization industry.

Since there is a very high level of regulatory compliance required by this industry as well as increased business risks (e.g. higher costs of drug discoveries, shortened market window opportunities,etc), CRO organizations would need to continuously focus on increasing ROI from their IT investments.

The potential for higher Technology usage remains e.g. as per an Oracle 2007 publication - Data Management in Pharmaceutical R & D, even today EDC (Electronic Data Capture) is used in only 35 % of clinical trials. 65 % still use paper based systems for trial data capture. More...

Oracle has signalled the Death of ERP Software License Fees in India having finally taken the plunge into Subscription Based Hosted ERP Services. This move is in line with the global fundamental shift in the software & services marketplace.

Likely response times for a large ORACLE FORMS application with thousands of users.

ORACLE has claimed 16,000 +
concurrent users with an average response time of 1.01
seconds for a large FORMS application. Many times, it is advisable to treat vendor claims with a pinch of salt.

Customers will have to do their own benchmarking with
a typical application mix, usage profile and proposed hardware
configuration in terms of make, configuration and number of Oracle
Application Servers.